- |||||||||| Phase classification: tDCS in MCS: Repeated Stimulations (clinicaltrials.gov) - Mar 31, 2017
P=N/A, N=20, Completed, Completed --> Terminated; The study was terminated because of lack of funding. Phase classification: P2 --> P=N/A
- |||||||||| tranexamic acid oral / Generic mfg.
Enrollment change, Trial initiation date, Trial withdrawal, Trial primary completion date: The Effect of Tranexamic Acid on Transfusion Rates in Intertrochanteric Hip Fractures (clinicaltrials.gov) - Mar 27, 2017 P4, N=0, Withdrawn, N=132 --> 32 | Suspended --> Terminated N=150 --> 0 | Initiation date: Aug 2014 --> Dec 2015 | Recruiting --> Withdrawn | Trial primary completion date: Aug 2016 --> Dec 2018
- |||||||||| Trial completion, Trial primary completion date: SpineTRACK Registry - Spinal Outcomes Registry (clinicaltrials.gov) - Mar 23, 2017
P=N/A, N=10000, Completed, Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2017 --> Sep 2017 Enrolling by invitation --> Completed | Trial primary completion date: Dec 2023 --> Dec 2016
- |||||||||| Phase classification, Enrollment change, Trial initiation date, Trial termination, Trial primary completion date: D2D: Vitamin D 2 to Dialysis Patients (clinicaltrials.gov) - Mar 15, 2017
P=N/A, N=18, Terminated, Trial primary completion date: Apr 2016 --> Apr 2017 Phase classification: P4 --> P=N/A | N=200 --> 18 | Initiation date: Sep 2010 --> Jun 2008 | Not yet recruiting --> Terminated | Trial primary completion date: Sep 2011 --> Jun 2009; Because of departure of study personnel and lack of funding
- |||||||||| Phase classification: The Teachable Moment: Screening and Brief Intervention for Admitted Trauma Patients (clinicaltrials.gov) - Mar 14, 2017
P=N/A, N=333, Completed, Phase classification: P4 --> P=N/A | N=200 --> 18 | Initiation date: Sep 2010 --> Jun 2008 | Not yet recruiting --> Terminated | Trial primary completion date: Sep 2011 --> Jun 2009; Because of departure of study personnel and lack of funding Phase classification: P2 --> P=N/A
- |||||||||| Enrollment closed, Enrollment change, Trial primary completion date: Cardiovascular, Cerebrovascular, and Cognitive Function in Spinal Cord Injury (clinicaltrials.gov) - Mar 10, 2017
P=N/A, N=61, Active, not recruiting, Active, not recruiting --> Completed | Initiation date: Jan 2013 --> Oct 2013 Recruiting --> Active, not recruiting | N=130 --> 61 | Trial primary completion date: Aug 2016 --> Jan 2017
- |||||||||| Phase classification, Trial primary completion date: Open Reduction Syndesmosis Tightrope Versus Screw Fixation (clinicaltrials.gov) - Mar 8, 2017
P=N/A, N=72, Recruiting, N=40 --> 2 | Recruiting --> Terminated | Trial primary completion date: Jan 2017 --> Mar 2016; Inadequate patient recruitment and coordinator left organization Phase classification: P4 --> P=N/A | Trial primary completion date: Sep 2016 --> Sep 2017
- |||||||||| Flector (diclofenac epolamine) / IBSA Institute Biochemical SA
Enrollment closed, Trial primary completion date: Safety Study of Flector Patch in Children With Minor Soft Tissue Injuries (clinicaltrials.gov) - Mar 7, 2017 P4, N=104, Active, not recruiting, N=60 --> 110 | Trial primary completion date: Jul 2016 --> Jul 2017 Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2017 --> Oct 2016
- |||||||||| tranexamic acid oral / Generic mfg.
Enrollment closed, Trial primary completion date: Prehospital Tranexamic Acid Use for Traumatic Brain Injury (clinicaltrials.gov) - Mar 7, 2017 P2, N=967, Active, not recruiting, Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2017 --> Oct 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2017 --> Oct 2017
- |||||||||| oxytocin / Generic mfg.
Trial completion, Trial primary completion date: FOLCROM Trial: Foley Catheter in Rupture of Membranes (clinicaltrials.gov) - Mar 7, 2017 P=N/A, N=201, Completed, Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2017 --> Oct 2017 Active, not recruiting --> Completed | Trial primary completion date: Dec 2016 --> Jul 2016
- |||||||||| Trial completion, Trial primary completion date: A Study to Assess the Long-term Performance of SmartSet (clinicaltrials.gov) - Mar 3, 2017
P4, N=243, Completed, Trial primary completion date: Jun 2016 --> Sep 2018 Active, not recruiting --> Completed | Trial primary completion date: Dec 2016 --> Jul 2016
- |||||||||| prazosin / Generic mfg.
Trial completion, Trial primary completion date: Prazosin Vibrostimulation Autonomic Dysreflexia and Spinal Cord Injury Study (clinicaltrials.gov) - Mar 3, 2017 P=N/A, N=7, Completed, Active, not recruiting --> Completed | Trial primary completion date: Dec 2016 --> Jul 2016 Recruiting --> Completed | Trial primary completion date: Dec 2011 --> Jul 2011
- |||||||||| ropivacaine / Generic mfg., epinephrine / Generic mfg.
Enrollment change, Trial termination, Trial primary completion date: Femoral Nerve Block for Femur Fracture Repair in Pediatrics (clinicaltrials.gov) - Mar 3, 2017 P2, N=19, Terminated, Trial primary completion date: Dec 2016 --> May 2017 N=40 --> 19 | Enrolling by invitation --> Terminated | Trial primary completion date: Dec 2017 --> Oct 2016; Interim analysis showed no significant difference between study arms.
- |||||||||| Phase classification, Head-to-Head: Written Exposure Therapy for Posttraumatic Stress Disorder (clinicaltrials.gov) - Mar 3, 2017
P=N/A, N=126, Active, not recruiting, N=40 --> 19 | Enrolling by invitation --> Terminated | Trial primary completion date: Dec 2017 --> Oct 2016; Interim analysis showed no significant difference between study arms. Phase classification: P2 --> P=N/A
- |||||||||| Trial completion, Enrollment change: IR and Microvascular Blood Flow in SCI (clinicaltrials.gov) - Mar 3, 2017
P=N/A, N=68, Completed, Recruiting --> Completed | N=300 --> 88 Recruiting --> Completed | N=160 --> 68
- |||||||||| Trial primary completion date: Insole Sensor to Determine Optimal Limb Loading (clinicaltrials.gov) - Feb 27, 2017
P=N/A, N=50, Enrolling by invitation, Trial primary completion date: Aug 2017 --> Aug 2018 Trial primary completion date: Jun 2017 --> Jun 2018
|